First Time Loading...

Chemomab Therapeutics Ltd
NASDAQ:CMMB

Watchlist Manager
Chemomab Therapeutics Ltd Logo
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Watchlist
Price: 0.7399 USD 0.64% Market Closed
Updated: May 4, 2024
CMMB
/
Income Statement
/
Net Income (Common)

Chemomab Therapeutics Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chemomab Therapeutics Ltd
Net Income (Common) Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
Chemomab Therapeutics Ltd
NASDAQ:CMMB
Net Income (Common)
-$24.2m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Net Income (Common)
-$7m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Net Income (Common)
$8.3m
CAGR 3-Years
-21%
CAGR 5-Years
-18%
CAGR 10-Years
34%
Urogen Pharma Ltd
NASDAQ:URGN
Net Income (Common)
-$102.2m
CAGR 3-Years
7%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Net Income (Common)
-$8.9m
CAGR 3-Years
7%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Net Income (Common)
-₪31m
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-12%

See Also

What is Chemomab Therapeutics Ltd's Net Income (Common)?
Net Income (Common)
-24.2m USD

Based on the financial report for Dec 31, 2023, Chemomab Therapeutics Ltd's Net Income (Common) amounts to -24.2m USD.

What is Chemomab Therapeutics Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-28%

Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for Chemomab Therapeutics Ltd have been -28% over the past three years .

ALPHA SPREAD
Join more than 133,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.